Loading...

immatics biotechnologies GmbH

IMTXW•NASDAQ
Healthcare
Biotechnology
$0.001
$-0.00(-88.46%)

immatics biotechnologies GmbH (IMTXW) Stock Overview

Explore immatics biotechnologies GmbH’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.3/100

Key Financials

Market Cap69.9K
P/E Ratio-31.08
EPS (TTM)N/A
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$0.03
1 Month$-0.84
3 Months$0.97
1 Year Target$1.40

IMTXW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of immatics biotechnologies GmbH (IMTXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.40.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.08 and a market capitalization of 69.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;